Full Approval Without Some Benefits: FDA Cautions Against Off-Label Use Of Pfizer’s COVID-19 Vaccine For Children, Boosters

 
• By Sarah Karlin-Smith
children waiting for train
Full approval still leaves young children waiting for COVID-19 vaccines. • Source: Alamy

More from Vaccines

More from Pink Sheet